Skip to main content
. 2016 Nov;51:56–64. doi: 10.1016/j.cct.2016.10.004
Assessments Prior to registration Prior to randomisation (end of run-in period) Months since randomisation
3 6 9 12 18 24 30 36 42 48 54 60
All cohorts
Main assessments Registration assessmentsa
End of run-in assessmentb
Follow-up assessmentsc
Intermittent assessments VES-13 questionnaire
(65 ≥ years at registration)
Cognitive assessment
Blood tests FBC, LFT, U&E & eGFR
C-Reactive Protein (CRP)
Fasting lipid profile
Other tests Tumour and blood sample
Breast cohort
Imaging Mammography
Colorectal cohort
Imaging and procedures CT (chest/abdomen/pelvis)
Colonoscopy
Blood tests CEA test
Prostate cohort
Blood tests PSA
Gastro-oesophageal cohort
No cohort specific investigations
a

Registration assessments include: eligibility, co-enrolment (if applicable), blood pressure, height, weight, blood results, concomitant medication and comorbidities.

b

End of run-in assessments include: symptoms and toxicity, adherence, blood pressure.

c

Follow-up assessments include: symptoms and toxicity, adherence, blood pressure, weight, concomitant medication.